Ontario narrows out-of-country drug funding rules after cancer patient court victory
An Ontario man with Stage 4 melanoma says the province has blocked access to funding for out-of-country drug treatments in response to his attempts to seek therapy in the U.S.
An Ontario man diagnosed with Stage 4 melanoma claims the province has effectively removed his access to public funding for out-of-country cancer treatments after a successful court victory. Alex Shved, a 37-year-old father of two, sought therapy in the United States, where tumour-infiltrating lymphocyte treatment costs approximately US$600,000. However, the Ontario Health Insurance Plan (OHIP) initially denied his oncologist’s request, citing that the therapy is under review for public funding in Ontario.
In response to Shved's pursuit of the therapy, the province's Divisional Court ruled that OHIP had no solid basis for its rejection, ordering the health insurance plan to reconsider. Despite this ruling, OHIP has rejected Shved's request for a third time. Health Minister Sylvia Jones announced that Ontario has amended its regulations to clarify that out-of-country drugs will only be funded if they are already funded within the province, but access is temporarily unavailable or delayed. The government is also exploring a "mutually satisfactory resolution" for Shved’s individual case.
Rewritten by urgent.news; may contain errors — check the original.
Sources: winnipegfreepress.com · globalnews.ca · cbc.ca · toronto.citynews.ca
This story
This is one outlet's version. Read the fullest account.
- Ontario narrows out-of-country drug funding rules after cancer patient court victory toronto.citynews.ca
- This Ontario man won a court case for Stage 4 cancer treatment in the U.S. Then the province changed the rules cbc.ca
- Ontario narrows out-of-country drug funding rules after cancer patient court victory globalnews.ca
- Ontario narrows out-of-country drug funding rules after cancer patient court victory winnipegfreepress.com
